Some information goes here
This box will hide on Careers page (disable by jQuery in navtop)
Debra Lappin is recognized across government, academic and non-profit sectors as a public servant and leading strategist in public health and science policy. She consults on innovative public-private partnerships, collaborative research and development agreements and other alliances to drive research translation and commercialization, advance policy agendas, and promote public health.
Debra's practice focuses on the influential role of non-profit and academic organizations as partners with government and industry to accelerate the movement of basic research into early phase clinical development. She advises on strategies to align stakeholders, develop cross-sector engagements to approach a policy, market or product challenge, and drive measurable solutions that will serve a client's mission and business purposes.
Debra has special expertise in advising on technologies that enable translation, such as disease registries, large integrated databases, bio-specimen repositories and cross-institution affiliations to share data. Debra's leadership in this sector includes campaigns on public access to scientific communications and genetic non-discrimination and the development of an NIH Cooperative Research and Development Agreement (CRADA) to move a repurposed drug forward in the treatment of rare blood cancer. She has also been instrumental in the formation coalitions to meet emerging public health threats, such as those posed by the rise in viral hepatitis and the incidences of unsafe injection practices across healthcare delivery settings.
Debra serves or has served as an advisor to the leaders of federal health agencies, including the Centers for Disease Control and Prevention and the National Institutes of Health, and has participated on a number of committees at the National Academy of Sciences, including the Committee on the Organizational Structure of the NIH that led to a number of reforms now institutionalized at NIH. She is President of the Council for American Medical Innovation and a member of the Board of Research! America.
Calling upon her experiences as former national chair of the Arthritis Foundation, she is a recognized national spokesperson on public engagement and patient-centricity in science and medicine.
*Your message has been successfully sent.
In considering prior results, please be aware that: (i) each matter is
unique; (ii) prior results are not necessarily representative of all our
matters; and (iii) you should not rely on prior results to predict future
success in similar matters.
Copyright © 2000-2013 Faegre Baker Daniels LLP.
All Rights Reserved. | Disclaimer
Notes: Please do not send confidential information or
sensitive materials through this form.
Transmission of information to us via this feature does not establish a privileged relationship. Do not send any information that you would have treated confidentially.